Coloplast doesn't expect impact from potential Russian gas halt
Coloplast has been working on phasing out natural gas use in its factories the world over in recent years, and today the Danish medtech company only uses natural gas to a limited extent.
by marketwire, translated by daniel pedersen
Danish medtech firm Coloplast is only expecting to be impacted to a very limited extent by the increasing cost of natural gas. Production issues aren’t in the cards even if the company was cut off from Russian gas completely, Coloplast writes in a comment to MarketWire.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Pharmaceutical firms prepare for potential Russian gas halt
For subscribers
Coloplast starts share buyback program
For subscribers
